Technical Analysis for PRTC - Puretech Health Plc

Grade Last Price % Change Price Change
B 206.50 -0.48% -1.00
PRTC closed down 0.48 percent on Friday, April 19, 2024, on 85 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Apr 25
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Down 1% about 14 hours ago
Fell Below Previous Day's Low about 15 hours ago
Fell Below Lower Bollinger Band about 15 hours ago
Possible NR7 about 15 hours ago
Lower Bollinger Band Support about 18 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Puretech Health Plc Description

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets. This segment includes subsidiary companies, which include Vedanta Biosciences, Inc., Gelesis, Inc., Akili Interactive Lab, Inc., Tal Medical, Inc., Karuna Pharmaceuticals, Inc., Entrega Inc. and Follica Incorporated. Businesses in the project phase businesses segment are those whose activities are focused on financing, sourcing and creating new product candidates and newly created businesses whose technologies are in the process of validation. This segment includes subsidiary companies, which include The Sync Project Inc., Sonde Health, Inc., Commense Inc., Alivio Therapeutics, Inc., Vor Biopharma Inc., Enlight Biosciences, LLC, Mandara Sciences, LLC and Knode Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Pharmaceutical Pharmaceuticals Science Sourcing Validation

Is PRTC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 242.925
52 Week Low 139.0
Average Volume 381,551
200-Day Moving Average 191.22
50-Day Moving Average 204.63
20-Day Moving Average 216.78
10-Day Moving Average 212.65
Average True Range 6.94
RSI (14) 43.50
ADX 19.78
+DI 16.61
-DI 17.65
Chandelier Exit (Long, 3 ATRs) 209.68
Chandelier Exit (Short, 3 ATRs) 225.32
Upper Bollinger Bands 227.95
Lower Bollinger Band 205.60
Percent B (%b) 0.04
BandWidth 10.31
MACD Line 0.74
MACD Signal Line 2.95
MACD Histogram -2.2125
Fundamentals Value
Market Cap 557.45 Million
Num Shares 270 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -1588.46
Price-to-Sales 43.10
Price-to-Book 1.24
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 214.00
Resistance 3 (R3) 214.17 211.83 212.75
Resistance 2 (R2) 211.83 209.92 211.75 212.33
Resistance 1 (R1) 209.17 208.74 208.00 209.00 211.92
Pivot Point 206.83 206.83 206.25 206.75 206.83
Support 1 (S1) 204.17 204.92 203.00 204.00 201.08
Support 2 (S2) 201.83 203.74 201.75 200.67
Support 3 (S3) 199.17 201.83 200.25
Support 4 (S4) 199.00